Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Allergan

More Headlines »« Less Headlines

Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.

Read More at Wikipedia ›

Related Topics

  1. Dow Jones
  2. Anheuser-Busch
  3. Duke Energy
  4. MetLife
  5. Merck
  6. InBev
Get updates on Allergan
UK's NICE Backs Allergan's Botox For Some Migraine Sufferers

The cost regulator for the U.

K.'s publicly-funded National Health Service has reversed its earlier stance on U.S.-based Allergan Inc.'s (AGN) wrinkle-fighting drug Botox and now recommends its use for some patients suffering from migraine headaches.The independent National Institute for Health and Clinical Excellence Friday said in final draft guidance that its advisory committee now recommends use of the injected medicine, known chemically as botulinum toxin type A, for some adult patients with chronic migraine, after NICE received more information on the product from the company. The body had previously said it was not convinced of the value of funding the therapy on the NHS.NICE director Carole Longson said in a statement; "we are pleased that the committee has been able to recommend Botox as a preventative therapy for those adults whose headaches have not improved despite trying at least three other medications and whose headaches are not caused by medication overuse."A chronic mig...

Read More ›

  1. US Court Blocks Sales Of Botox Alternative

    A U.S. district court issued an injunction against a maker of a Botox alternative that was accused of misappropriating trade secrets belonging to Allergan Inc. (AGN)...

  2. Allergan : Sales Of Botox Alternative Blocked For 10 Months

    Allergan Inc. (AGN) said a U.S. district court issued a permanent injunction against a maker of a Botox alternative that was accused of violating California's Unifor...

  3. Allergan : US Court Bars Merz Sales Of Xeomin For 10 Months

    DOW JONES NEWSWIRESAllergan Inc. (AGN) said a U.S. district court issued a permanent injunction against Merz Pharmaceuticals and Merz Aesthetics in connection with a...

  4. Acadia, Allergan Extend Ophthalmology Collaboration By A Year

    DOW JONES NEWSWIRESAcadia Pharmaceuticals Inc. (ACAD) extended its drug discovery and development collaboration in the area of ophthalmology with Allergan Inc. (AGN)...

  5. UK Body Not Convinced Allergan's Botox Can Be Used For Migraines

    Patients with migraine may not get access to Botox on the National Health Service in England and Wales as cost regulators say they are inclined not to back funding f...

  6. Botox Sales Boost Allergan ’s 4Q Earnings

    Allergan CEO David Pyott on rising sales for Botox, particularly in emerging markets such as China.

  7. Allergan 4Q Net Rises 6.3% On Eye Care Sales

    Allergan Inc.'s (AGN) fourth-quarter earnings rose 6.3% on an increase in specialty pharmaceuticals sales, despite higher research and development costs.Specialty ph...

  8. Allergan 4Q Net Rose 6.3%, Margins Improve; R&D Costs Higher

    (" Allergan 4Q Net Falls 6.3% On Higher R&D Costs; Margins Improve," at 9:56 a.m. EST, misstated the earnings change direction in the headline and first and fourth p...

  9. Allergan 4Q Net Falls 6.3% On Higher R&D Costs; Margins Improve

    DOW JONES NEWSWIRESAllergan Inc.'s (AGN) fourth-quarter earnings fell 6.3% on a sharp rise in research and development costs and one-time items, though the Botox mak...

  10. Week Ahead: April Jobs Report and Car Sales

    The U.S. unemployment rate is widely expected to stay put at 8.8% when the April labor report is released on Friday. Despite those broad expectations, investors are ...

  11. Merck to Buy Inspire Pharma For $430M

    Merck & Co said Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals Inc for about $430 million to expand its ophthalmology business.Inspire's key pr...

  12. Hospira Appoints Allergen's Mike Ball as CEO

    For the first time since its 2004 spin-off from Abbott Laboratories (NYSE:ABT), Hospira (NYSE:HSP) has named a new chief executive.Current Allergan (NYSE:AGN) presid...

  1. Allergan's Profit Rises 45% On Stronger Botox Sales

    Allergan Inc.'s (AGN) first-quarter earnings rose 45% as the maker of Botox and medical devices reported double-digit sales growth at its specialty pharmaceuticals b...

  2. Chesapeake Energy Corporation, Herbalife Among Stocks Down on Above-average Volume Wednesday

    These are stocks that are down on high volume today:Chesapeake Energy Corporation (NYSE:CHK) is down on high volume today, trading with volume of 82.7 million, or 1....

  3. Allergan 1Q Profit Rose 45% On Stronger Specialty Drug Sales

    DOW JONES NEWSWIRESAllergan Inc.'s (AGN) first-quarter earnings rose 45% as the maker of Botox and medical devices reported double-digit sales growth at its specialt...

  4. Starbucks Corporation, Visa Included in Stocks Up on High Volume Friday

    A few stocks are up on high volume today:Starbucks Corporation (NASDAQ:SBUX) experienced a price hike on above-average volume today, trading at a volume of 15.2 mill...

  5. Map Pharmaceuticals Plans FDA Meeting To Discuss Manufacturing Issues

    DOW JONES NEWSWIRESMap Pharmaceuticals Inc. (MAPP) plans to meet with the Food and Drug Administration during the current quarter to discuss manufacturing issues tha...

  6. Allergan : Studies Show Botox Treats Overactive Bladder

    Allergan Inc. (AGN) filed applications with U.S. and European regulators for approval to sell Botox as a treatment for overactive bladder as new data showed the inje...

  7. Botox Moving Beyond Just Face Lifts

    Botox is best known for erasing frown lines on middle-aged celebrities, but it may soon have a less glamorous role in the healthcare industry. Drug giant Allergan (N...

‹ Prev12Next ›
Freebase CC-BY
Source: Allergan on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL